Education
About Us
Working with TipRanks
Follow Us
Cocrystal Pharma Inc (COCP)
NASDAQ:COCP
Total Valuation
Cocrystal Pharma has a market cap or net worth of $13.02M. The enterprise value is $12.42M.
Market Cap$13.02M
Enterprise Value$12.42M
Share Statistics
Cocrystal Pharma has 10.17M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10.17M
Owned by Insiders51.52%
Owned by Instutions0.10%
Financial Efficiency
Cocrystal Pharma’s return on equity (ROE) is -0.68 and return on invested capital (ROIC) is -65.73%.
Return on Equity (ROE)-68.16%
Return on Assets (ROA)-57.53%
Return on Invested Capital (ROIC)-65.73%
Return on Capital Employed (ROCE)-66.29%
Revenue Per Employee$12,000
Profits Per Employee-$1,558,500
Employee Count12
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Cocrystal Pharma is -0.92. Cocrystal Pharma’s PEG ratio is <0.01.
PE Ratio-0.92
PS Ratio0.00
PB Ratio0.63
Price to Fair Value0.63
Price to FCF-1.12
Price to Operating Cash Flow-1.13
PEG Ratio<0.01
Income Statement
In the last 12 months, Cocrystal Pharma had revenue of $144.00K and earned -$18.70M in profits. Earnings per share was -$1.85.
Revenue$144.00K
Gross Profit$4.00K
Operating Income-$20.31M
Pretax Income-$18.70M
Net Income-$18.70M
EBITDA-18.95M
Earnings Per Share (EPS)-1.85
Cash Flow
In the last 12 months, operating cash flow was -$16.19M and capital expenditures -$57.01K, giving a free cash flow of -$11.74M billion.
Operating Cash Flow-$16.19M
Free Cash Flow-$11.74M
Free Cash Flow per Share-$1.15
Dividends & Yields
Cocrystal Pharma pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-89.06%
Earnings Yield-108.34%
Stock Price Statistics
Beta0.45
52-Week Price Change-9.22%
50-Day Moving Average1.67
200-Day Moving Average1.92
Relative Strength Index (RSI)35.46
Average Volume (3m)18.33K
Important Dates
Cocrystal Pharma upcoming earnings date is May 19, 2025, TBA.
Last Earnings DateMar 31, 2025
Next Earnings DateMay 19, 2025
Ex-Dividend Date―
Financial Position
Cocrystal Pharma as a current ratio of 8.92, with Debt / Equity ratio of 0.07
Current Ratio8.92
Quick Ratio8.92
Debt to Market Cap0.00
Net Debt to EBITDA1.26
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Cocrystal Pharma has paid -$30.48K in taxes.
Income Tax-$30.48K
Effective Tax Rate0.00%
Enterprise Valuation
Cocrystal Pharma EV to EBITDA ratio is 0.41, with an EV/FCF ratio of 0.53.
EV to Sales0.00
EV to EBITDA0.41
EV to Free Cash Flow0.53
EV to Operating Cash Flow0.54
Balance Sheet
Cocrystal Pharma has $13.02M in cash and marketable securities with $1.88M in debt, giving a net cash position of -$11.14M billion.
Cash & Marketable Securities$13.02M
Total Debt$1.88M
Net Cash-$11.14M
Net Cash Per Share-$1.10
Tangible Book Value Per Share$2.73
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Cocrystal Pharma is $8.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$8.50
Price Target Upside564.06%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast9.46%